New number of shares and voting rights of Innate Pharma

On November 28, 2025, Innate Pharma SA published information regarding the number of shares comprising its share capital and the number of associated voting rights, in accordance with French regulations. As of November 27, 2025, the company, listed on Euronext Paris and Nasdaq, held 92,196,523 ordinary shares, 6,334 2016 preference shares, and 7,581 2017 preference shares.

The number of theoretical voting rights is 92,962,943, while the number of exercisable voting rights is 92,944,368. This information is crucial for investors and financial market participants to assess the capital structure and the possibilities of influencing corporate decisions.